Droplet microfluidics provide a robust platform to
synthesize and functionalize micro- and nanoparticles in a range of
applications, including drug delivery, screening, lab-on-a-chip and
organ-on-a-chip applications, across chemical and biomedical
engineering. Chitosan is a biomaterial suited for diverse
biomedical applications, including antibacterial bioactivities with
immune-enhancing and anticancer properties. In a new report now
published in Scientific Reports, Omid Sartipzadeh and an
interdisciplinary research team in medical nanotechnology,
biomaterials and tissue engineering, in Tehran, Iran, described the
role of chitosan droplets in a microfluidic chip. The outcomes
indicated how different sizes and geometries of the chitosan
droplets could be established by varying the parameters for several
purposes including drug delivery, tissue engineering and cell
encapsulation. The team conducted an experimental study that agreed
with the simulation outcomes to confirm the results.